98%
921
2 minutes
20
Recent evidence suggests that snail predators may aid efforts to control the human parasitic disease schistosomiasis by eating aquatic snail species that serve as intermediate hosts of the parasite. Potential synergies between schistosomiasis control and aquaculture of giant prawns are evaluated using an integrated bio-economic-epidemiologic model. Combinations of stocking density and aquaculture cycle length that maximize cumulative, discounted profit are identified for two prawn species in sub-Saharan Africa: the endemic, non-domesticated , and the non-native, domesticated . At profit maximizing densities, both and may substantially reduce intermediate host snail populations and aid schistosomiasis control efforts. Control strategies drawing on both prawn aquaculture to reduce intermediate host snail populations and mass drug administration to treat infected individuals are found to be superior to either strategy alone. Integrated aquaculture-based interventions can be a win-win strategy in terms of health and sustainable development in schistosomiasis endemic regions of the world.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731924 | PMC |
http://dx.doi.org/10.1038/s41893-019-0301-7 | DOI Listing |
PLoS Negl Trop Dis
September 2025
Pelagic Ecology Research Group, School of Biology, Gatty Marine Laboratory, Scottish Oceans Institute, University of St Andrews, St Andrews, Fife, United Kingdom.
In areas of high infection prevalence, effective control of schistosomiasis - one of the most important Neglected Tropical Diseases - requires supplementing medical treatment with interventions targeted at the environmental reservoir of disease. In addition to provision of clean water, reliable sanitation, and molluscicide use to control the obligate intermediate host snail, top-down biological control of parasite-competent snails has recently gained increasing interest in the scientific community. However, evidence that natural predators can effectively reduce snail abundance and, ultimately, transmission risk to vulnerable human populations remains limited.
View Article and Find Full Text PDFPLoS Negl Trop Dis
September 2025
School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom.
Direct morbidity assessments are rarely included in monitoring and evaluation of Schistosoma mansoni mass drug administration programmes. This is despite morbidity reduction being the leading objective of control and elimination as a public health problem in the World Health Organization (WHO) targets. Instead, the number of eggs-per-gram (EPG) of faeces are used as a morbidity proxy.
View Article and Find Full Text PDFJ Parasit Dis
September 2025
Laboratory of Immunity and Biodiversity, Department of Biology, Faculty of Sciences Aïn Chock, University Hassan II, Km 8 Route d'El Jadida B.P 5366, Maarif, Casablanca Morocco.
Schistosomiasis, a parasitic disease caused by species, affects millions of people worldwide. This review explores the therapeutic challenges of schistosomiasis, focusing on the mechanisms of action of current treatments and their limitations. Praziquantel, the standard therapy, induces lesions and muscle contractions in the parasites, thereby facilitating their clearance by the host immune system.
View Article and Find Full Text PDFBMC Immunol
September 2025
Department of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Centre, Omaha, USA.
Background: Urogenital schistosomiasis caused by affects over 100 million people globally, with potential long-term genetic and immunological consequences poorly understood in endemic populations. This study investigates genetic damage and immune dysregulation in infected individuals from a hyperendemic region in Nigeria.
Objective: To quantify genetic damage markers and characterize immune system alterations in individuals with confirmed infection compared to uninfected controls from Atisbo Local Government Area, Oyo State, Nigeria.
Trop Med Health
September 2025
RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.
Background: Schistosomiasis is a neglected tropical disease caused by parasitic flatworms of the genus Schistosoma. Currently, praziquantel is the only medication available for treating schistosomiasis. However, crucial issues regarding drug resistance, reinfection, and prevention remain unresolved.
View Article and Find Full Text PDF